Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Summary

Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels through lifestyle interventions and, along with the correction of vitamin D and magnesium, can alleviate nonspecific back pain in prediabetic patients.

Timeline

Start

2023-01-30

Primary completion

2023-08-30

Completion

2023-09-01

Drugs

Indications